California State Teachers Retirement System (CalSTRS)’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.81M Buy
77,159
+161
+0.2% +$5.85K ﹤0.01% 1186
2025
Q1
$2.79M Sell
76,998
-1,053
-1% -$38.1K ﹤0.01% 1166
2024
Q4
$3.28M Buy
78,051
+268
+0.3% +$11.3K ﹤0.01% 1107
2024
Q3
$4.32M Buy
77,783
+4,342
+6% +$241K 0.01% 988
2024
Q2
$3.02M Sell
73,441
-972
-1% -$39.9K ﹤0.01% 1122
2024
Q1
$3.47M Sell
74,413
-2,662
-3% -$124K ﹤0.01% 1086
2023
Q4
$3.69M Sell
77,075
-603
-0.8% -$28.8K 0.01% 1074
2023
Q3
$2.77M Sell
77,678
-6,807
-8% -$243K ﹤0.01% 1204
2023
Q2
$3.9M Buy
84,485
+982
+1% +$45.3K 0.01% 1098
2023
Q1
$3.35M Sell
83,503
-1,272
-2% -$51K 0.01% 1167
2022
Q4
$3.93M Buy
84,775
+1,083
+1% +$50.2K 0.01% 1080
2022
Q3
$3.47M Sell
83,692
-3,959
-5% -$164K 0.01% 1118
2022
Q2
$5.23M Buy
87,651
+1,692
+2% +$101K 0.01% 930
2022
Q1
$6.24M Sell
85,959
-6,927
-7% -$503K 0.01% 935
2021
Q4
$7.81M Sell
92,886
-18,242
-16% -$1.53M 0.01% 885
2021
Q3
$10M Sell
111,128
-6,223
-5% -$561K 0.01% 816
2021
Q2
$11.2M Buy
117,351
+15,683
+15% +$1.5M 0.01% 786
2021
Q1
$11.6M Buy
101,668
+1,181
+1% +$134K 0.02% 743
2020
Q4
$13.9M Buy
100,487
+7,675
+8% +$1.06M 0.02% 643
2020
Q3
$7.63M Buy
92,812
+7,292
+9% +$599K 0.01% 790
2020
Q2
$6.69M Buy
85,520
+2,465
+3% +$193K 0.01% 809
2020
Q1
$3.69M Sell
83,055
-411
-0.5% -$18.3K 0.01% 973
2019
Q4
$3.57M Sell
83,466
-1,687
-2% -$72.1K 0.01% 1218
2019
Q3
$3.64M Buy
85,153
+1,018
+1% +$43.6K 0.01% 1170
2019
Q2
$5.34M Buy
84,135
+3,641
+5% +$231K 0.01% 957
2019
Q1
$5.58M Buy
80,494
+5,711
+8% +$396K 0.01% 909
2018
Q4
$3.25M Buy
74,783
+2,851
+4% +$124K 0.01% 1158
2018
Q3
$5.49M Sell
71,932
-24
-0% -$1.83K 0.01% 975
2018
Q2
$5.53M Buy
71,956
+4,095
+6% +$315K 0.01% 948
2018
Q1
$3.46M Buy
67,861
+5,465
+9% +$279K 0.01% 1176
2017
Q4
$2.89M Sell
62,396
-948
-1% -$44K 0.01% 1336
2017
Q3
$3.37M Sell
63,344
-6,762
-10% -$360K 0.01% 1239
2017
Q2
$4.35M Sell
70,106
-5,739
-8% -$356K 0.01% 1114
2017
Q1
$5.14M Buy
75,845
+1,600
+2% +$108K 0.01% 1040
2016
Q4
$5.22M Sell
74,245
-2,000
-3% -$141K 0.01% 1056
2016
Q3
$5.41M Buy
76,245
+700
+0.9% +$49.7K 0.01% 1008
2016
Q2
$3.7M Sell
75,545
-6,126
-8% -$300K 0.01% 1207
2016
Q1
$5.17M Buy
81,671
+10,499
+15% +$665K 0.01% 1001
2015
Q4
$7.98M Buy
71,172
+1,100
+2% +$123K 0.02% 713
2015
Q3
$6.75M Buy
70,072
+4,500
+7% +$433K 0.02% 790
2015
Q2
$6.71M Buy
65,572
+51,447
+364% +$5.27M 0.02% 856
2015
Q1
$877K Buy
14,125
+1,100
+8% +$68.3K ﹤0.01% 2106
2014
Q4
$572K Buy
13,025
+55
+0.4% +$2.42K ﹤0.01% 2396
2014
Q3
$734K Buy
12,970
+870
+7% +$49.2K ﹤0.01% 2210
2014
Q2
$543K Buy
12,100
+100
+0.8% +$4.49K ﹤0.01% 2449
2014
Q1
$587K Buy
+12,000
New +$587K ﹤0.01% 2326